As part of its work within the ATTC Network, Dr Matthew Lakelin, PhD VP Business Development and Scientific Affairs at TrakCel, has written a white paper. The paper examines the challenges of addressing patient- and product-centric needs for advanced therapy supply; this is achieved by reviewing the supply of different advanced therapies to highlight the issues of delivering cell therapy medicinal products efficiently, compliantly and safely in a cost-effective manner.

The white paper can be viewed here: